Common Contracts

KURVE THERAPEUTICS, INC., A DELAWARE CORPORATION COMMON STOCK SHARES REGULATION A+ SUBSCRIPTION AGREEMENT

+ Subscription Agreement • September 29th, 2022 • Kurve Therapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  + Subscription Agreement
• Filed
  September 29th, 2022
• Company
  Kurve Therapeutics, Inc.
• Industry
  Pharmaceutical preparations

Investing in securities represented by shares of common stock (“Shares”) of Kurve Therapeutics, Inc. (the “Company”) involves significant risks. This investment is suitable only for persons who can afford to lose their entire investment and such investment could be illiquid for an indefinite period of time. No public market currently exists for the Shares, and if a public market develops following this offering, it may not continue.

FACIBLE BIODIAGNOSTICS, INC., A DELAWARE CORPORATION CLASS A COMMON STOCK SHARES REGULATION A+ SUBSCRIPTION AGREEMENT

Subscription Agreement • September 27th, 2022 • Facible BioDiagnostics, Inc. • Services-medical laboratories

• Contract Type
  Subscription Agreement
• Filed
  September 27th, 2022
• Company
  Facible BioDiagnostics, Inc.
• Industry
  Services-medical laboratories

Investing in securities represented by shares of Class A common stock (“Shares”) of Facible BioDiagnostics, Inc. (the “Company”) involves significant risks. This investment is suitable only for persons who can afford to lose their entire investment and such investment could be illiquid for an indefinite period of time. No public market currently exists for the Shares, and if a public market develops following this offering, it may not continue.

MCGINLEY ORTHOPAEDIC INNOVATIONS, INC., A WYOMING CORPORATION COMMON STOCK SHARES REGULATION A+ SUBSCRIPTION AGREEMENT

Subscription Agreement • August 11th, 2022 • McGinley Orthopaedic Innovations, Inc.

• Contract Type
  Subscription Agreement
• Filed
  August 11th, 2022
• Company
  McGinley Orthopaedic Innovations, Inc.

Investing in securities represented by shares of common stock (“Shares”) of McGinley Orthopaedic Innovations, Inc. (the “Company”) involves significant risks. This investment is suitable only for persons who can afford to lose their entire investment and such investment could be illiquid for an indefinite period of time. No public market currently exists for the Shares, and if a public market develops following this offering, it may not continue.